OPINION | CAR T-cell therapy is proving to be promising in the treatment of solid tumours
Date 21-Sep-2024 | By : Dr Gaurav KharyaChimeric Antigen Receptor T-cell (CAR T-cell) therapy has been used and is fast becoming a treatment of choice for patients suffering from blood cancers like leukemia and lymphoma
It is time to prioritise Sickle Cell Disease care in India
Date 19-Jun-2024 | By : Dr Gaurav KharyaSickle cell disease (SCD) is a severe hereditary blood disorder that poses a significant public health challenge in India, particularly in regions with high malaria rates, known as the "sickle belt," which extends from West Bengal, Orissa, Jharkhand, Madhya Pradesh, Chhattisgarh, and Bihar to Maharashtra and Gujarat.
How cell and gene therapies revolutionising cancer care in India
Date 10-Jul-2024 | By : Dr Gaurav KharyaOur body is made up of cells, and whatever happens to it—good or bad—happens at a cellular level. Cancer, for example, occurs due to a small change in the cell that prompts it to proliferate abnormally. Also, cancer spreads in the body because the immune cells lose their ability to identify the danger cancer cells pose and stop them from growing. We treat cancer by surgically removing the cancer cells from the body or by giving drugs that kill the malignant cells.
Rewriting our DNA: The potential of gene editing for blood disorders and beyond
Date 17-Aug-2024 | By : Dr Gaurav KharyaGene editing, particularly with CRISPR-Cas9 technology, has shown potential to revolutionise medicine by offering cures for a range of genetic disorders, especially blood disorders such as sickle-cell anaemia.
Young and Thriving
Date 03-Feb-2016 | By : Gunjan SharmaNavdeep Kaur is chirpy, her eyes bright as she watches a movie on her tablet during the last cycle of chemotherapy at BLK Hospital in Delhi. So contagious is her cheerfulness that her grandmother Gurmail Kaur, who is sitting beside her, is hardly nervous.